0 menciones esta semana
0
Social
Noticias
Blog
Moderna and Merck cancer vaccine cuts melanoma recurrence by 44% in late-stage trial
hace 6d
Moderna and Merck vaccine cuts melanoma recurrence risk by 44% in phase 3 study
